Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 25, 2024, titled "Press Release on Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2024.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 25, 2024, titled "Press Release on Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2024.".